Aspira Offers Pfizer Vaccine
Aspira is offering the Pfizer vaccine to all patients age 12 years and older.
We do not charge for the vaccine. However, if you have active insurance you must present it at the time of your vaccination.
We vaccinate anyone regardless of citizenship or immigration status.
We have a Vaccine Hotline: (302) 212-9096.
3rd (Booster) Dose for Immunocompromised:
On August 12, 2021 the FDA expanded the EUA for the Pfizer-BioNTech Vaccine to authorize a third dose of the same COVID-19 vaccine administered at least 28 days following the two-dose regimen of either vaccine.
This authorization is limited and only applies to eligible individuals who have undergone solid organ transplant or who are diagnosed with conditions that are considered to have an equivalent level of immunocompromise.
The following individuals should be considered for a 3rd dose of mRNA vaccine, if they have received their first dose:
- Organ transplant recipients taking immunosuppressive therapy
- Recipient of stem cell transplants (CAR-T-cell or hematopoietic) within two years or taking immunosuppressive therapy
- Active/recent cancer treatments for tumors or hematologic malignancies
- Advanced or untreated HIV infection
- Persons taking medications that weaken the immune system – high-dose corticosteroids (i.e., ≥20mg prednisone or equivalent per day), alkylating agents, antimetabolites, transplant-related immunosuppressive drugs, cancer chemotherapeutic agents classified as severely immunosuppressive, TNF blockers, and other biologic agents that are immunosuppressive or immunomodulatory
- Moderate or severe primary immunodeficiency (e.g., DiGeorge, Wiskott-Aldrich syndromes)
Aspira will vaccinate anyone that meets the above criteria. We accept patients on a Walk-In basis.
LOCATION & TIMES:
Daily: Aspira Health (8AM-8PM) Vaccines are available routinely on a walk-in basis. You can walk in to our facility any time and request the vaccine.
St Jude’s Parish Hall: We have been approved to return to the Hall after booster shots become FDA/CDC/ACIP approved. Check back for details.
Pfizer-BioNTech COVID-19 Vaccine: The schedule is one dose (0.3mL), followed by a second identical dose (0.3mL) in 21 days.
The Pfizer vaccine was intended to be boosted (the second dose) with only another Pfizer vaccine. Do not switch to Moderna or Johnson & Johnson. While there is no evidence of any adverse reactions when switching vaccines, there is also no evidence that you will get the immunity boost that is desired with a second dose. Studies are limited on this but more information may be forth-coming in the future.
Qualifying & Scheduling a Vaccination
[May 11 Update] The FDA has authorized use of the Pfizer vaccine for 12 to 15-year olds. Aspira will vaccinate anyone age 12 and older.
WHAT IF I’M PREGNANT OR BREASTFEEDING:
If pregnant women are part of a group that is recommended to receive a COVID-19 vaccine (e.g., healthcare personnel), they may choose to be vaccinated. When making a decision, pregnant women and their healthcare providers should consider the level of COVID-19 community transmission, the patient’s personal risk of contracting COVID-19, the risks of COVID-19 to the patient and potential risks to the fetus, the efficacy of the vaccine, the side effects of the vaccine, and the lack of data about use of the vaccine during pregnancy.
A lactating woman who is part of a group recommended to receive a COVID-19 vaccine (e.g., healthcare personnel) may choose to be vaccinated. There are no data on the safety of COVID-19 vaccines in lactating women or the effects of COVID-19 vaccines on the breastfed infant or milk production/excretion (2).
COVID Vaccine - Scientific Literature Updates
Up to date information on COVID, brought to you by Aspira. Click on the images and links below to read the full stories.
[May 3, 2021] It is reported that the Pfizer vaccine will soon be available to patients age 12-15. Aspira is working with schools to get kids vaccinated. Check back for news updates.
[March 31, 2021] The Pfizer vaccine is extremely effective in adolescents 12 to 15 years old, perhaps even more so than in adults, the companies reported. No infections were found in the study group and the participants produced strong antibody responses.
[March 29, 2021] Pfizer’s vaccine has proven to provide powerful protection to individuals that complete the vaccination schedule. Among those patients that were fully vaccinated, there were 0.04 infections per 1,000 person-days, meaning that among 1,000 persons there would be 0.04 infections in a day.
SECOND DOSE WINDOW: 17 – 42 DAYS AFTER FIRST
[Jan 26, 2021] Pfizer and the Delaware Division of Public Health have stated that the second dose can be given up to 42 days (6 weeks) after the first dose and the patient still benefits from a boost in immunity. Studies have shown that this is a safe and effective strategy.
Persons should not be scheduled to receive the second dose earlier than recommended (i.e. 3 weeks for the Pfizer-BioNTech). However, second doses administered within a grace period of 4 days earlier than the recommended date for the second dose are still considered valid (3). Therefore, because of limited supply availability, it is ok to receive your second dose from Aspira anywhere between 17 and 25 days after the first for optimal administration.
If you cannot get the 2nd dose right away, do not worry. Patients still get between 50-83% immunity from just one shot. By comparison, the flu vaccine only offers between 45-55% immunity each year. Simply continue to search for access and get vaccinated when you are able.
Scheduling a 2nd dose: Anyone who received their first dose from Aspira will receive an email 1-3 days before their second dose is due to let them know either (a) how to schedule their second dose at Aspira, or (b) where they might be able to find a second dose.
We appreciate your patience in this matter. When doses are available, scheduling will be open to the public. Right now, public scheduling is not available.